Antimicrobial Resistance (AMR) is the greatest global health challenge of our time. New antibiotics are desperately needed to combat drug-resistant bacteria and improve patient care.


We have developed a powerful, next-generation antibiotic to combat AMR — WT13-12. WT13-12 exhibits remarkable performance characteristics, and is currently in preclinical trials.

Contact Us

We seek to create real solutions to stem the spread of AMR. If you share our vision, we’d love to hear from you.